Title
Description
This is an infographic comparing general perspectives on Abuse-Deterrent Formulations guidances by the US Food and Drug Administration (FDA). The left half shows the perspective of an Innovator and the right half shows the perspective of a Generic. Both share the same beginning (Category 1 = In vitro laboratory testing & Category 2 = PK testing) but Innovator has additional levels (Category 3 = HAP testing & Category 4 = Post-marketing studies).
Type
Category
Source 1 of 3
-
Date
2016
Collection
-
Date
2016
Collection
-
Date
2016
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.
